Biodesix (BDSX) Asset Writedowns and Impairment (2019 - 2026)
Biodesix (BDSX) posted Asset Writedowns and Impairment of $5000.0 for Q1 2026, up 108.77% quarter-over-quarter from -$57000.0 in Q4 2025, and down 93.15% year-on-year from $73000.0 in Q1 2025.
Biodesix (BDSX) Asset Writedowns and Impairment (2019 - 2026) Analysis & Trends
Biodesix (BDSX) has reported Asset Writedowns and Impairment for 8 consecutive years, with $5000.0 the latest figure, recorded in Q1 2026.
- Asset Writedowns and Impairment for Q1 2026 came in at $5000.0, down 93.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$19000.0 (down 107.82% YoY), and the FY2025 annual result was $49000.0, down 79.41% from the prior year.
- Asset Writedowns and Impairment was $5000.0 for Q1 2026 at Biodesix, up from -$57000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $539000.0 in Q2 2022 and troughed at -$419000.0 in Q3 2022.
- Average Asset Writedowns and Impairment over 5 years is $36562.5, with a median of $28000.0 recorded in 2023.
- Year-over-year, Asset Writedowns and Impairment surged 770.0% in 2024 and plunged 155.34% in 2025.
- Over 5 years, Asset Writedowns and Impairment stood at $12000.0 in 2022, then jumped by 733.33% to $100000.0 in 2023, then increased by 3.0% to $103000.0 in 2024, then sank by 155.34% to -$57000.0 in 2025, then jumped by 108.77% to $5000.0 in 2026.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $5000.0 in Q1 2026, -$57000.0 in Q4 2025, and $7000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Biodesix | 236.57 Mn | 211.00 Mn | 21.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | -57,000.00 |
| Dec 31, 2025 | -57,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2024 | 103,000.00 |
| Dec 31, 2024 | 103,000.00 |
| Jun 30, 2024 | 67,000.00 |
| Jun 30, 2024 | 67,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Mar 31, 2024 | 68,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 80,000.00 |
| Sep 30, 2023 | 80,000.00 |